Sponsor or institution
Clinical trials and research at Institut Cancerologie de l'Ouest
As of November 12, 2026, Find a Trial lists 10 clinical trials run by Institut Cancerologie de l'Ouest that are recruiting, at sites in 3 countries (most in France (10), Germany (1), Spain (1)). By phase: Phase 3 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 3Countries
Newest trials
All recruiting trials (10)
-
SRT for bone and lymph node metastases in advanced prostate cancer
This trial tests whether treating multiple metastatic lesions with stereotactic radiotherapy can prolong pain control and prevent complications in men with advanced, treatment‑refractory prostate cancer.
-
CXCR4-targeted [68Ga]Ga-PentixaFor PET/CT imaging for metastatic triple-negative breast cancer
This study will test whether a CXCR4-targeted PET/CT scan ([68Ga]Ga-PentixaFor) can better detect metastatic triple-negative breast cancer than the standard [18F]FDG PET/CT in adults.
-
Using sophrology to reduce anxiety in breast cancer patients undergoing chemotherapy
This study is testing if a relaxation technique called sophrology can help reduce anxiety in breast cancer patients who are receiving chemotherapy.
-
Corticodependent or corticoresistant brain radionecrosis after radiotherapy for brain metastases
This trial tests whether the drug bevacizumab helps people with steroid‑dependent or steroid‑resistant brain radionecrosis following radiotherapy for brain metastases.
-
Predicting blood clot risks in cancer patients
This study is testing if measuring certain blood factors can help predict blood clot risks in cancer patients who are at high risk for complications during treatment.
-
Predicting breast cancer treatment responses using advanced analysis techniques
This study is testing if advanced analysis techniques can help predict how early breast cancer patients will respond to chemotherapy, especially for those with tougher subtypes like triple-negative and HER2-positive breast cancer.
-
Capsaicin patch compared to oral duloxetine for chemotherapy-induced nerve pain
This study is testing whether a capsaicin patch or an oral medication called duloxetine works better to relieve nerve pain in cancer patients who have had chemotherapy.
-
Clinical and biological data collection for metastatic lung cancer
This project will test whether a prospective database that combines clinical, imaging, psychological and multi-omic information can help predict which treatments will work best for people with metastatic lung cancer.
-
Neoadjuvant hormone therapy for extensive ductal carcinoma in situ
This study is testing if giving hormone therapy before surgery can help women with extensive ductal carcinoma in situ avoid a mastectomy and have better treatment outcomes.
-
Observing the use of Ziconotide for treating severe chronic pain
This study looks at how well Ziconotide works for people with severe chronic pain and whether it’s safe to use in real-life situations.
Quick answers
How many clinical trials run by Institut Cancerologie de l'Ouest are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in France (10 trials), Germany (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.